Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

Clinical trial NCT06350890 · COMPLETED

Trial details

NCT number: NCT06350890
Sponsor: Shenzhen HighTide Biopharmaceutical Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2023-11-05
Primary completion: 2024-12-12
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.